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Summary: Pantoea agglomerans has been classically associated with
cellulitis or synovitis secondary to penetrating trauma by vegeta-
tion. It is an infrequent cause of systemic infections. We describe
the case of a 5-year-old girl with sickle cell disease with P.
agglomerans bacteremia and review its potential causes.
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BACKGROUND
Pantoea agglomerans, formerly known as Enterobacter
agglomerans, is a gram-negative nonencapsulated aerobic
bacillus member of the Enterobacteriaceae family.1 It is a
ubiquitous microorganism that can be found in soil, plants,
water, feces, and foodstuﬀs1,2 and an opportunistic pathogen
that very rarely causes disease in healthy individuals.1,3
Immunodeﬁciency is an established risk factor.4 Most infec-
tions are classically cellulitis, arthritis, or synovitis secondary to
penetrating trauma by vegetation,1–4 but P. agglomerans
nosocomial bacteremia is also well-described. It is usually
associated with indwelling catheters,5 contaminated intra-
venous (IV) ﬂuids,2 and blood products.6 Cases of liver
abscess7 and endophtalmitis8 have been documented. Bacterial
translocation from the gut during gastroenteritis has also been
postulated.9
OBSERVATION
A 5-year-old girl with a medical history of pre-
maturity, failure to thrive, and homozygous SS sickle cell
disease (under amoxicillin prophylaxis) with prior admis-
sion for acute chest syndrome presented to the emergency
department with a history of high-grade fever for the past
three days (391C) and productive cough. Other than pre-
viously known pallor, mild jaundice, and systolic murmur,
her physical examination was unremarkable. Laboratory
values showed anemia with a hemoglobin (Hb) of 7.8 g/dL,
leukocytosis (36,300/mL, 78% neutrophils), thrombocytosis
(489,000/mL), and an increased C-reactive protein (CRP) of
45.2mg/L (reference value <5.0mg/L). The chest x-ray
performed was normal. She was admitted with the diag-
nosis of fever of unknown origin and was started on IV
cefotaxime (100mg per kg per day) according to the
protocol.
After 24 hours on IV antibiotics, she was afebrile. The
blood culture obtained on admission was sterile. Despite
clinical improvement, hospitalization was prolonged due to
the development of lumbar and abdominal pain attributed to
vasoocclusive crisis. On day 7, laboratory evaluation revealed
signiﬁcant hemolysis, with a decrease in Hb concentration
(7.0 g/dL), elevation of lactate dehydrogenase (485U/L; ref-
erence value 110-295 U/L) and elevation of total bilirrubin
(1,59mg/dL; reference value 0.3-1.2 mg/dL), increased leu-
kocyte count (23,700/mL), and CRP (26,6mg/L). The patient
received a unit of packed red blood cell transfusion. During
the transfusion, she developed high fever (391C) that persisted
for 4 days (every 8h, 38,51C). Lab testing was remarkable for
worsening leukocytosis (38,900/mL) and CRP (76,8mg/L).
Antibiotic therapy was broadened with the addition of IV
metronidazole and vancomycin. Blood samples were drawn
into aerobic and anaerobic blood culture bottles (BacT/Alert
FA; bioMerieux, Mercy l’Etoile, France). After a 12-hour
incubation period (incubator BacT/Alert 3D; bioMerieux,
Mercy l’Etoile, France), the aerobic blood culture was pos-
itive for P. agglomerans sensitive to amoxicillin/clavulanic
acid, cefuroxime, and cefotaxime. For strain identiﬁcation,
MALDI-TOF Mass Spectrometry (Vitek MS system, bio-
Me´rieux, Marcy l´E´toile, France), reported to be a reliable
method for the identiﬁcation of the genus Pantoea,10 con-
ﬁrmed the strain. Therefore, molecular conﬁrmation of
P. agglomerans identity was not considered necessary.
No other eﬀects of bacteremia were observed; the
patient remained hemodynamically stable and did not
require additional transfusional support.
The patient denied prior penetrating trauma or diar-
rhea and had no central venous line that could help
establish an underlying cause for Pantoea bacteremia. After
questioning, the mother referred pica in the 6 months
before admission (ingestion of wall paint and soil).
Unfortunately, environmental samples (glucose sol-
utions and transfused blood) cultures were not performed.
There were no other Pantoea infections reported in the
hospital in this period. Other reported associations were not
found in this case: there was no history of gastrointestinal
symptoms or lesions or recent antiacid administration.
Also, cotton pledgets are not used in our institution and
plants and ﬂowers are forbidden in the interior of the
hospital, ruling out these as possible contamination
sources.
Four days later, the patient was afebrile and clinically
well. Blood culture was repeated and sterility documented.
The patient was discharged on day 17 of hospitalization,
back to her usual state of health after a total course of 17
days of IV cefotaxime, 10 days of IV metronidazole and
vancomycin, and was discharged on oral amoxicillin/
clavulanic (total of 10 d of antimicrobial therapy after
positive blood culture).
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DISCUSSION
Previous reports have implicated Pantoea spp in sys-
temic infections in immunocompromised hosts.11 Sickle cell
disease patients are known to have impaired immunity
beyond functional asplenia.12,13 Achkar et al4 have already
reported a case of P. agglomerans bacteremia in a sickle cell
disease patient. In addition, P. agglomerans bacteremia has
been associated with blood type A, as was the blood type of
this patient.14
Infections caused by P. agglomerans are usually asso-
ciated with an identiﬁable exogenous source.3 In this case,
we identiﬁed several factors that could explain Pantoea spp
bacteremia.
The patient denied plant injury, but admitted ingestion
of soil and wall paint six months before admission, which
could explain the contamination, followed by translocation
reaching the bloodstream and causing infection, a mecha-
nism described previously.4,9
Despite pica being remarkably common in sickle cell
pediatric patients15 and bacterial translocation a relatively
frequent occurrence in this patient population due to focal gut
mucosal ischemia, Pantoea bacteremia is not frequent in these
patients, which reduces the likelihood of pica as a source in
this case. Also, a positive culture that occurred while the
patient was under antimicrobial therapy to which the isolate
was highly sensitive also argues against that hypothesis.
The fact that a P. agglomerans-positive culture
occurred after hospitalization and while the patient was
under antibimicrobial therapy to which the isolate was
highly sensitive also argues against that hypothesis.
Although it is diﬃcult to draw a deﬁnite conclusion, it is
tempting to assume that this case of P. agglomerans bac-
teremia might represent nosocomial contamination, possi-
bly related to packed red blood cell transfusion.
CONCLUSIONS
This case illustrates a very rare cause of bacteremia in
sickle cell patients and the multitude of confounding factors
that can be present, making the establishment of a timeline
diﬃcult. It is important to exclude nosocomial infection to
prevent hospital outbreaks.
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